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Abstract  51 
Streptococcus (S.) agalactiae is a leading cause of morbidity and mortality among neonates 52 
and causes severe infections in pregnant women and nonpregnant predisposed adults, as well 53 
as various animal species worldwide. Still, information on the population structure of S. 54 
agalactiae and the geographical distribution of different clones is limited. Further data is 55 
urgently needed to identify particularly successful clones and obtain insights into possible 56 
routes of transmission within one host species and across species borders. We aimed to 57 
determine the population structure and virulence gene profiles of S. agalactiae strains from a 58 
diverse set of sources and geographical origins. To this end, 373 S. agalactiae isolates 59 
obtained from humans and animals from five different continents were typed by DNA 60 
microarray profiling. A total of 242 different S. agalactiae strains were identified and further 61 
analyzed. Particularly successful clonal lineages, hybridization patterns, and strains were 62 
identified that were spread across different continents and/or were present in more than one 63 
host species. In particular, several strains were detected both in humans and cattle, and several 64 
canine strains were also detected in samples from human, bovine, and porcine hosts. The 65 
findings of our study suggest that while S. agalactiae is well adapted to various hosts 66 
including humans, cattle, dogs, rodents, and fish, interspecies transmission is possible and 67 
occurs between humans and cows, dogs, and rabbits. The presented virulence and resistance 68 
gene profiles enable new insights into interspecies transmission and make a crucial 69 
contribution in the identification of suitable targets for therapeutic agents and vaccines.  70 
 71 
 72 
Keywords: genotype B Streptococci, GBS, transmission, capsular serotype, resistance, 73 
clonality 74 
Morach 2017 
 5 
Introduction 75 
  Streptococcus (S.) agalactiae, also known as group B Streptococcus (GBS), emerged 76 
in the 1970s as a major cause of morbidity and mortality in neonates and pregnant women. 77 
The organism leads to meningitis and septicemia in newborns and severe peripartum 78 
complications in pregnant women [1]. S. agalactiae has been linked to disease in the elderly 79 
and in nonpregnant adults suffering from chronic diseases [2,3]. The organism is also 80 
commonly found in food [4] and there are some indications for foodborne/ feedborne 81 
transmission [5–7]. In spite of numerous eradication programs, S. agalactiae is still a common 82 
cause of bovine intramammary infections in many countries [8], with particularly high herd 83 
prevalence levels in countries with emerging dairy industries [9]. 84 
Capsular polysaccharide (CPS) was recognized as a major virulence factor of S. 85 
agalactiae and plays an important role in the evasion of host defence mechanisms. CPS has 86 
also been used to type GBS and assign isolates to distinct CPS serotypes (Ia, Ib, and II to IX), 87 
with serotypes Ia, Ib, II, III and V being highly prevalent in human invasive GBS isolates in 88 
many regions of the world [10–12]. Vaccines combining these serotypes can be highly 89 
effective, they fail however to offer protection against other GBS serotypes, which cause the 90 
majority of GBS infections in some regions of the world such as Japan [11,12]. 91 
GBS strains can harbour a wide range of genes encoding virulence factors such as Bac 92 
involved in immune evasion, the alpha-like proteins involved in invasion, or the pilus islands, 93 
which play a role in host adaptation and specificity. GBS also frequently exhibit resistance 94 
genes, including genes conferring resistance to macrolide, lincosamide, and tetracycline. 95 
Recently, several studies typing and characterizing S. agalactiae isolates have been published 96 
[13–19] and a tool for rapid GBS typing based on DNA microarray hybridization patterns 97 
(HPs) has been introduced [13]. However, comprehensive information on the population 98 
structure and virulence gene profiles of S. agalactiae and the geographical distribution of 99 
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different clonal lineages is extremely scarce. In particular, comprehensive data on the 100 
population structure and virulence gene profile of isolates from a broad range of host species 101 
is missing. This data would be crucial to obtain further insights into host adaptation, to 102 
identify particularly successful clones, and to determine the geographical distribution of 103 
different clonal lineages. It could also be used to identify suitable targets for vaccines and 104 
antimicrobial agents, and to further elucidate possible routes of transmission.  105 
A prospective cross-sectional cohort study found that exposure to cattle is a predictor 106 
of human colonization with S. agalactiae [20]. Case reports and some GBS typing data 107 
indicate possible transmission not only between human hosts and cows, but also human hosts 108 
and dogs, cats, and crocodiles [21–25]. In addition, experimental studies have evidenced 109 
transmission of bovine and human S. agalactiae strains to fish [26–28]. Still, data on 110 
interspecies transmission is scarce and strain typing studies involving a diverse set of hosts 111 
and geographical areas are missing.  112 
Therefore, here we provide data on the population structure and virulence gene 113 
profiles of S. agalactiae strains isolated from a diverse set of hosts and a wide variety of 114 
geographical areas.  115 
 116 
  117 
Morach 2017 
 7 
Material and methods 118 
Bacterial isolates  119 
In this study, a total of 373 S. agalactiae isolates from 5 different continents were 120 
analyzed. Countries of origin represented in this study were: Belgium (n = 1), Colombia (n = 121 
86), Costa Rica (n = 1), Germany (n = 109), Honduras (n = 3), Hong Kong SAR, China (n = 122 
30), Kenya (n = 33), Switzerland (n = 103), Thailand (n = 6), Vietnam (n = 1). Isolates 123 
included in this study originated from human hosts (n = 225), cattle (n = 84), dogs (n = 16), 124 
fish (n = 15), mice (n = 11), elephants (n = 7), guinea pigs (n = 3), emerald monitors (n = 3), 125 
rats (n = 2), snakes (n = 2) and one isolate each was collected from a rabbit, a goat, a pig, a 126 
turtle, and a frog. A full summary stating the host species, geographical source, and sample 127 
type is provided as Online Resource 1.  128 
 129 
DNA extraction and DNA microarray  130 
All isolates other than fish isolates were cultivated on 5% sheep blood agar (Oxoid 131 
Limited, Hampshire, UK) and incubated for 48 to 72 hours at 37°C. S. agalactiae isolates 132 
obtained from fish were streaked on both sheep blood agar and Tryptic Soy Agar (Becton 133 
Dickinson), and incubated for 72 hours at 30°C. Subsequent DNA extraction was performed 134 
using a Qiagen DNeasy kit and following the recommendations of the DNA microarray 135 
S.agaType AS-1 kit provider (Alere Technologies, Jena, Germany). As this protocol proved 136 
unsuccessful in fish isolates, these isolates were cultivated in 10 mL Tryptic Soy Broth and/or 137 
10 mL Brain Heart Infusion and incubated at 28°C and at 200 rpm/min for 48h or until 138 
clouding of the broth culture was visible. The following day, cells were harvested by 139 
centrifugation and dissolved in A1 lysis buffer, before transfer to the A2 lysis enhancer 140 
Eppendorf tube, to which 400 U achromopeptidase was added. Subsequent steps were 141 
performed according to the manufacturer`s protocol (Alere Technologies). A ND-100 UV-Vis 142 
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spectrophotometer (NanoDrop Technologies, Wilmington, Germany) was used to measure 143 
DNA concentrations in all samples.  144 
The DNA microarray used in this study provides data on the presence/absence of typing 145 
markers (capsule/pilus-associated genes and alp genes), as well as genes conferring resistance 146 
(resistance to macrolide/ lincosamide antibiotics, tetracycline, heavy metals) or encoding 147 
virulence factors, enzymes and other metabolic functions [13]. Linear PCR amplification and 148 
DNA microarray hybridization, washing steps, and staining were performed as suggested by 149 
the DNA microarray manufacturer. Hybridization patterns and signal intensities were 150 
measured applying an ArrayMate reader (Alere Technologies) and were used for S. agalactiae 151 
species confirmation, assignment to a clonal complex and capsule type, hybridization pattern, 152 
and strain, where possible [13]. 153 
 154 
SplitsTree analysis 155 
Similar to Coombs et al., DNA microarray hybridization profiles were used to 156 
calculate unrooted phylogenetic networks from molecular sequence data [29,30]. Stringent 157 
inclusion criteria were applied to avoid bias. Multiple isolates were considered to represent 158 
the same strain (e.g. S1) if DNA microarray hybridization results were identical for all 159 
positive/negative signals. In these cases, only one S. agalactiae DNA microarray profile was 160 
considered for construction of the SplitsTree and was included in the statistical analysis. This 161 
resulted in a total number of 161 strains from humans, 52 strains from ruminants, 15 strains 162 
from dogs, 8 strains form rodents, 8 strains from fish, and 12 strains from other hosts being 163 
included in the statistical analysis. SplitsTree4 (www.splitstree.org) was used to depict the 164 
degree of similarity of the different S. agalactiae hybridization patterns [31].  165 
 166 
Statistical analysis  167 
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Statistically significant differences (p  0.050) in the distribution of virulence and 168 
resistance genes between isolates from different sources (hosts or host groups) were 169 
determined either by Chi squared test or Fisher’s exact test (in case n < 5) using SPSS 24.0 170 
(IBM Corp., Armonk, NY, USA). 171 
 172 
Results 173 
The 373 GBS isolates included in this study could be assigned to 242 different strains. 174 
Multiple isolates representing the same strain were detected in many host species and across 175 
different countries or continents (see Table 1). We observed particularly high rates of 176 
duplicates assigned to the same strain among murine (64%), piscine (47%), and bovine 177 
isolates (39%). In addition, isolates representing the same S. agalactiae strains were not only 178 
detected multiple times within one host species, but in some cases also across different host 179 
species (see Fig. 1). 180 
We determined pronounced host-specific differences in the frequency of different 181 
clonal complexes (Table 2). In GBS from human hosts, CC19-19 was most prevalent (35%), 182 
followed by CC23 (20%). In contrast, GBS strains isolated from ruminants were most 183 
commonly assigned to CC23 (21%), strains from dogs to CC19-10 (40%), strains from 184 
rodents to CC19-01 (75%), and strains from fish to CC260/261 (75%). Some host-specific 185 
differences were also visible in the prevalence of capsular serotypes (Table 3). While serotype 186 
IB was highly prevalent in GBS strains from fish (63%), it was only rarely detected in isolates 187 
from other hosts. In contrast, serotypes IA, II, III, and V were common in GBS from different 188 
host species. As illustrated in the SplitsTree (see Fig. 2), the S. agalactiae strains investigated 189 
in this study also exhibited highly heterogeneous DNA microarray hybridization profiles. 190 
With the exception of S. agalactiae isolated from fish, no distinct clustering of strains based 191 
on host species, geographical origin, or clonal complex assignment could be observed.  192 
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The prevalence of selected virulence and resistance genes among different host groups 193 
is presented in Table 4. Depending on the host, different combinations and variants of the 194 
pilus island gene clusters were observed. The speM gene encoding exotoxin M was detected 195 
in only one isolate (S209, CC19-19), originating from a recto-vaginal swab from a patient in 196 
China. With regard to the allelic variants of the alpha-like GBS surface proteins, the allele 197 
alp_rib (R4) was significantly more prevalent in strains of human origin than in strains from 198 
all other sources.  The bac gene encoding a GBS surface protein was frequently present in 199 
isolates from dogs. In addition, the genes of the first pilin gene cluster (pilA/B/C-I) were more 200 
common in canine GBS isolates, whereas prevalence was low in fish isolates. In contrast, the 201 
pilA/B/C-2b genes of the second pilin gene cluster were significantly more prevalent in GBS 202 
from fish compared with GBS isolated from humans, dogs, and rodents. The vast majority of 203 
human isolates (94%) harbored scpB, which encodes for C5a peptidase and is used as a 204 
diagnostic marker.  205 
As for genes conferring resistance to antimicrobial agents, the emrB/qacA multidrug 206 
resistance transporter gene was present in all tested strains. The majority of strains also 207 
exhibited tetM, a gene associated with tetracycline resistance, and cadD, involved in cadmium 208 
resistance. Among human and canine strains, we frequently detected merA/R, genes involved 209 
in mercuric resistance. Online Resource 2 provides a comprehensive overview of the 210 
frequency of all virulence and resistance genes detected among the different host groups, as 211 
well as p-values for statistically significant differences. Full DNA microarray hybridization 212 
patterns of all strains are included in Online Resource 3. 213 
 214 
Discussion 215 
To date, data on GBS interspecies transmission is limited. In particular, the zoonotic 216 
potential and the directionality of transmission of GBS infections are poorly understood. 217 
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Experimental studies showed the transmissibility of various bovine and human GBS strains to 218 
fish [26–28] and characterization and genotyping studies suggested occasional transmission 219 
between humans and cattle [23,24]. Very recently, transmission of S. agalactiae through 220 
ingestion of raw fish sushi was reported to have led to severe infections in humans 221 
(Kalimuddin et al., 2017). In addition, cases of GBS infections acquired through contact with 222 
GBS from other host species have been reported: necrotizing fasciitis and endocarditis cases 223 
in humans occurred after a dog [25] and a cat bite [21], respectively, and necrotizing fasciitis 224 
cases in a group of crocodiles were likely of human origin [22].  225 
In our study, isolates from various hosts were assigned to the same strain, suggesting 226 
interspecies transmission. Five GBS strains were detected in at least one bovine and one 227 
human host, and another strain was detected in a human, a bovine, and two canine hosts. In 228 
addition, a canine and a porcine isolate were assigned to the same strain. The relatively high 229 
number of S. agalactiae strains identified in both a sample from a dog and at least one other 230 
host species is particularly striking, considering that only 15 canine strains were included in 231 
this study. However, the data provided in this study does not allow for conclusions regarding 232 
the directionality of transmission. In addition, it needs to be taken into consideration that the 233 
strain collection tested predominantly comprises human and bovine GBS strains originating 234 
from Europe, which may bias results. 235 
Nitschke et al. [13] introduced GBS typing based on DNA microarray hybridization 236 
patterns and provided data on human GBS from Germany and the Caribbean, as well as 237 
bovine GBS from Germany: The most prevalent hybridization patterns detected were HP-01 238 
(CC19-01), HP-30 (CC19-17), HP-35 (CC19-19), and HP-48 (CC23), corresponding to the 239 
whole-genome sequenced reference strains CJB111, COH1, Gottschalk 1003A, and Strain 240 
515, respectively. All four hybridization patterns were also frequently detected in our study, 241 
with HP-01 being linked to the most diverse set of hosts. GBS of HP-01 originated from 242 
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humans (n = 5), cows (n = 3), dogs (n = 2), mice (n = 3), emerald monitors (n = 2), a rat (n = 243 
1), and a snake (n = 1). GBS of HP-30 originated from human hosts (n = 10), a rabbit (n = 1), 244 
a cow (n = 1), and a goat (n = 1). GBS of HP-35 originated from humans (n = 8), a dog (n = 245 
1), and a cow (n = 1), and GBS of HP-48 were detected in human (n = 15), bovine (n = 3), 246 
and canine (n = 2) hosts.   247 
The versatility and wide spread of these strains becomes evident, when considering the hosts 248 
and geographical locations, in which some of the strains investigated in this study were 249 
isolated: S60/S250/S256 (HP-01) was detected in a sample from the skin of a dog in Germany, 250 
as well as in a human vaginal swab from China, and bovine mastitis milk in Germany. 251 
S117/S254 (HP-30) was identified in a sample from a rabbit in Germany, as well as in human 252 
samples in Germany and Colombia. S185/S255 (HP-35) was detected in a sample from the 253 
paw of a dog in Germany, and vaginal swabs from women in Colombia and Switzerland. 254 
This study provides comprehensive data on the occurrence of capsular serotypes 255 
among human and animal GBS isolates. CPS typing data is not only essential for 256 
epidemiological purposes, but is also needed in the development of effective CPS-based 257 
vaccines [11,12,32]. 258 
Among the GBS strains investigated in this study, we frequently detected genes 259 
conferring resistance to antimicrobial agents and heavy metal resistance markers. Genes 260 
associated with macrolide/ clindamycin resistance were exclusively found among GBS from 261 
humans, ruminants, dogs, and a pig. Various recent studies report that 15-21% of GBS strains 262 
isolated from pregnant women or cases of neonatal GBS infections are resistant to macrolide 263 
and/or lincosamide  [33–35]. The high prevalence of tetM detected in our study in human 264 
(76%) and ruminant (48%) strains is consistent with findings of Nitschke and colleagues, 265 
which reported prevalence rates of 78% and 71% in human GBS from Germany and the 266 
Caribbean, as well as 48% in bovine GBS from Germany [13].  267 
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In our study, 40% of the canine strains and 25% of fish strains exhibited bac, while the 268 
gene was only detected in 13% of GBS strains from human origin. The bac gene encodes the 269 
C protein beta antigen (Bac), which is able to simultaneously bind to the Fc fragment of IgA 270 
and the complement regulator factor H, thus likely contributing to immune evasion [32,36]. In 271 
addition, increased Bac expression was reported in invasive strains compared to strains 272 
collected from vaginal carriers [37]. Previous studies have associated bac sequence types with 273 
capsular serotype assignment [37,38]. In contrast to our findings, a study investigating human 274 
GBS from Asia, Australia, Europe, New Zealand, and North America found that bac was 275 
present in 97% of serotype Ib isolates and 37% of serotype II isolates, while being largely 276 
absent in GBS assigned to other serotypes [38].  277 
Low prevalence of the speM gene encoding exotoxin M has been reported among GBS 278 
from human and bovine sources [13]. This is consistent with our findings. In this study, we 279 
detected speM in only one isolate (S209, CC19-19) originating from a recto-vaginal swab 280 
from a patient in China.  281 
In our study, the alpha-like GBS surface protein allele alp_rib (R4) (= R4, rib) was 282 
significantly more prevalent in strains of human origin than in strains from all other sources. 283 
The alpha-like proteins are chimeras forming mosaic structures on the surface of the organism 284 
[39]. While the function of many alpha-like proteins is still poorly understood, they may act 285 
as invasins mediating adherence to cervical epithelial cells, as well as transmembrane passage 286 
and translocation of the organism [39].  287 
In our study, different hosts were associated with different combinations and allelic 288 
variants of genes of the pilus islands. Each of the three pilus islands (Pl-1, Pl-2a, Pl2b) 289 
encodes one backbone and two ancillary proteins that mediate interactions with host cells. The 290 
pilus islands and their combinations were shown to play an important role in host adaptation 291 
and specificity, as well as disease presentation [40].  292 
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The findings of our study suggest that while S. agalactiae is well adapted to various hosts 293 
including humans, cattle, dogs, rodents, and fish, interspecies transmission is possible and 294 
occurs amongst others between humans and cows, dogs, and rabbits. Involvement of a canine 295 
host in interspecies transmission events may be particularly frequent, with the directionality of 296 
transmission still being unclear. The virulence and resistance gene patterns determined in our 297 
study significantly extend the limited current knowledge on interspecies transmission. They 298 
could also be utilized in the identification of suitable targets for therapeutic agents, as well as 299 
vaccines. 300 
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Figure legends 431 
 432 
Fig 1 Interspecies transmission. Several S. agalactiae strains were detected in samples from 433 
more than one host species, indicating interspecies transmission. This figure provides an 434 
overview of the links detected and their frequency.  435 
 436 
Fig 2 SplitsTree. SplitsTree illustrating the degree of similarity of virulence and resistance 437 
gene profiles of S. agalactiae strains from different sources: Human host (pink), ruminant 438 
(green), dog (orange), elephant (grey), fish (blue), rodent/rabbit (yellow), other (purple). 439 
Strains detected in two or more host species are marked by red circles. 440 
  441 
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Tables 442 
 443 
Table 1: Clonal lineages and strains identified in more than one continent and across 444 
multiple host species. In some clonal complexes, strains were isolated more than once, some 445 
of them beyond country borders and from different host species.  446 
Clonal 
complex 
Strain Source Sample Countrya 
CC19-01 S48/S244/S245 Rat (n = 1) Abscess CH 
  Monitor (n = 2) Lung/ kidney/ liver/ intestine DE 
  Mouse (n = 3) Intestine DE 
 S53 Mouse (n = 5) Intestine DE 
 S57/ S249 Snake (n = 2) Liver, skin DE 
  Monitor (n = 1) Liver DE 
 S60/S250/S256 Dog (n = 2) Skin DE 
  Human (n = 4) Vaginal swab HK 
  Bovine (n = 2) Milk DE 
 S61/S251 Rat (n = 1) Trachea DE 
  Mouse (n = 2) Prepuce DE 
 S63 Bovine (n = 4) Milk DE 
 S64 Bovine (n = 3) Milk  DE 
 S65 Bovine (n = 2) Milk  DE 
 S69 Bovine (n = 5) Milk  DE 
 S81 Human (n = 2) Vaginal swab  HK 
 S84 Human (n = 2) Vaginal swab  HK 
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 S92 Human (n = 2) Vaginal swab  HK 
 S102 Human (n = 2) Vaginal swab, abdominal 
tissue 
HK, KY 
CC19-02 S3 Guinea pig (n = 2) Nose, liver DE 
 S7 Bovine (n = 2) Milk DE 
CC19-10 S58/S252 Bovine (n = 1) Organs DE 
  Human (n = 3) Urine, vaginal swab, wound CO, CH, KY 
 S66 Bovine (n = 2) Uterus, milk DE 
 S68 Bovine (n = 3) Milk DE 
 S73 Human (n = 2) Pus, urine CO 
 S85 Human (n = 2) Vaginal swab  HK 
 S90 Tilapia (n = 4) Kidney TH 
 S91 Tilapia (n = 2) Kidney TH, VN 
 S112 Human (n = 2) Urine, blood KY 
CC19-17 S116 Human (n = 4) Mastitis, blood, vaginal swab DE, CO, CH 
 S117/S254 Rabbit (n = 1) Unknown DE 
  Human (n = 4) Vaginal swab, urine  CO, CH 
 S120 Elephant (n = 3) Abscess/ foot DE 
 S126 Bovine (n = 2) Milk DE 
 S152 Human (n = 3) Vaginal swab  HK 
 S153 Human (n = 2) Vaginal swab  CH 
 S157 Human (n = 2) Vaginal swab  CH 
 S169 Human (n = 4) Vaginal swab  CH 
 S175 Human (n = 4) Blood, urine, vaginal swab KY 
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CC19-19 S186/S255 Dog (n = 1) Paw DE 
  Human (n = 4)  Vaginal swab, urine CO, CH 
 S190 Human (n = 2) Urine, vaginal swab CO 
 S193 Human (n = 2) Urine CO 
 S195 Human (n = 3) Urine, vaginal swab CO 
 S197 Human (n = 2) Vaginal swab  CO 
 S198 Human (n = 2) Urine, blood CO 
 S218 Human (n = 2) Vaginal swab  CH 
 S222 Human (n = 2) Vaginal swab CH, KY 
 S227 Human (n = 3) Vaginal swab  CH 
 S235 Human (n = 2) Vaginal swab CH 
 S237 Human (n = 2) Blood, vaginal swab KY, CO 
CC19-67 S5/S243 Dog (n = 1) Skin DE 
  Bovine (n = 1) Milk CH 
 S17 Bovine (n = 4) Milk CO 
 S23 Bovine (n = 2) Milk CH 
CC23 S124/248 Dog (n = 1) Skin DE 
  Pig (n = 1) Milk DE 
 S128 Bovine (n = 2) Milk DE 
 S130 Bovine (n = 2) Milk DE 
 S133 
S134/S253 
Bovine (n = 3) 
Bovine (n = 1)  
Human (n = 3) 
Milk 
Milk 
Urine, vaginal swab 
DE 
DE 
CO, HK 
 S135 Bovine (n = 2) Milk DE 
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 S137 Human (n = 12) Vaginal swab, biopsy, urine, 
blood 
CO, CH, KY 
 S139 Human (n = 3) Urine, blood, secretion CO 
 S141 Human (n = 2) Vaginal swab, urine CO 
 S142 Human (n = 2) Vaginal swab CO 
 S145 Human (n = 3) Vaginal swab  CH, CO 
 S162 Human (n = 3) Vaginal swab CH 
CC103 S11/S247 
 
S14  
Bovine (n = 1) 
Human (n = 1) 
Bovine (n = 5) 
Milk 
Pus 
Milk 
DE 
CO 
DE 
 S16/S246 Bovine (n = 1) Milk DE 
  Human (n = 1) Urine CO 
CC260/261 S31 Tilapia (n = 2) Spleen, kidney HN, CO 
 S32 Tilapia (n = 3) Spleen, kidney HN, CO 
CC298 S19 Bovine (n = 3) Milk CO 
not assigned S10 Bovine (n = 2) Milk DE 
 S18 Bovine (n = 2) Milk CO 
a Country abbreviations: CH = Switzerland, CO = Colombia, DE = Germany, HK = Hong 447 
Kong SAR (China), HN = Honduras, KY = Kenya, TH = Thailand, VN = Vietnam 448 
 449 
 450 
 451 
 452 
 453 
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Table 2. Clonal complex distribution. This table provides an overview of the prevalence of 454 
different clonal complexes among S. agalactiae strains from various hosts (in percent).  455 
 456 
Clonal complex Hosts (% of strains) 
Human 
(n = 161) 
Ruminant 
(n = 52) 
Dog  
(n = 15) 
Rodent  
(n = 8) 
Fish  
(n = 8) 
Other 
(n = 12) 
CC19-01 12 19 13 75 0 25 
CC19-02 4 2 7 25 0 0 
CC19-04 1 0 0 0 0 0 
CC19-10 12 12 40 0 25 17 
CC19-17 10 6 0 0 0 17 
CC19-19 35 4 13 0 0 0 
CC19-22 2 0 0 0 0 0 
CC19-67 1 13 7 0 0 8 
CC23 20 21 20 0 0 33 
CC26 1 0 0 0 0 0 
CC103 2 10 0 0 0 0 
CC130 1 0 0 0 0 0 
CC260/261 0 0 0 0 75 0 
CC298 0 2 0 0 0 0 
not assigned 0 12 0 0 0 0 
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Table 3: Prevalence of capsular serotypes.  457 
 458 
Capsular serotype Hosts (% of strains) 
Human 
(n = 161) 
Ruminant 
(n = 52) 
Dog  
(n = 15) 
Rodent  
(n = 8) 
Fish  
(n = 8) 
Other 
(n = 12) 
IA 16 35 20 0 13 25 
IB 9 8 7 0 63 0 
II 17 19 20 50 0 0 
III 22 21 13 0 13 33 
IV 4 10 13 0 0 0 
V 21 8 20 50 0 25 
VI  1 0 0 0 0 0 
VII 2 0 0 0 0 0 
IX 1 0 0 0 0 0 
negative 2 0 0 0 13 17 
not assignable 5 0 7 0 0 0 
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Table 4. Virulence and resistance genes. Prevalence of selected virulence and resistance genes among GBS strains isolated from different hosts: 
humans, ruminants, dogs, rodents, fish, and other (snake, turtle, frog, elephant, pig, rabbit). A comprehensive list of DNA microarray results including p-
values is provided as Supplementary Table 2. 
Gene Function Host (% of strains) 
  Human 
(n = 161) 
Ruminant  
(n = 52) 
Dog  
(n = 15) 
Rodent 
(n = 8) 
Fish  
(n = 8) 
Other  
(n = 12) 
 
Virulence genes 
speM Exotoxin M 1 0 0 0 0 0 
cylD Beta hemolysin locus 96*F 100*F 100*F 100*F 25*HRDXY 100*F 
cylE Beta hemolysin locus 87*F 94*F 100*F 100*F 25*HRDXY 100*F 
alp_3 Allele of the -like protein/ -antigenic cell wall protein 7*X 10*X 13*X 75*HRDF 0*X 25 
alp_rib (R4) Allele of the -like protein/ -antigenic cell wall protein 52*RXFY 24*H 20 0*H 0*H 9*H 
bac -antigenic cell wall protein 13*D 15 40*H 0 25 8 
pilA1 Pilin gene cluster 1 51 50 80*F 71 25*D 50 
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pilB1 Pilin gene cluster 1 63 48*D 80*RF 75 25*D 50 
pilC1 Pilin gene cluster 1 66 56 80 75 38 50 
pilA2a Pilin gene cluster 2a 81*RFY 52*HDX 87*RF 100*RFY 13*HDX 50*HX 
pilC2a Pilin gene cluster 2a 82*RF 52*HDX 93*RF 100*RF 13*HDX 58 
pilA2b pilin gene cluster 2b 15
*RFY 48*HDX 7*RF 0*RF 63*HDX 42*H 
pilB2b Pilin gene cluster 2b 15*RFY 48*HDX 7*RF 0*RF 67*HDX 42*H 
pilC2b Pilin gene cluster 2b 14*RFY 48*HDX 7*RF 0*RF 75*HDX 42*H 
scpB-var1 Complement-inactivating C5a peptidase 94*RDXFY 50*H 67*HF 25*H 13*HD 27*H 
scpB-var2 Complement-inactivating C5a peptidase 94*RDXFY 48*H 67*HF 25*H 13*HD 25*H 
fsb-var3 Allele of a fibrinogen binding protein 61*X 46*X 73*F 100*HRFY 25*DX 33*X 
 
Resistance genes 
cadC Cadmium efflux system accessory protein 21*R 2*H 13 0 0 0 
cadD Cadmium resistance protein 75*F 77*F 93*FY 100*FY 14*HRDX 50*DX 
emrB/qacA Multidrug resistance transporter 100 100 100 100 100 100 
ermA Macrolide/clindamycin resistance 9 2 13 0 0 8 
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ermB Macrolide/clindamycin resistance 19 10 7 0 0 0 
ermC Macrolide/clindamycin resistance 0 0 0 0 0 0 
merA Mercuric reductase 58*RXFY 11*HD 45*R 0*H 13*H 10*H 
merR Mercuric resistance operon regulatory protein 57*RXFY 12*H 33 0*H 13*H 17*H 
tetM Tetracycline resistance 76*RF 48*HD 93*RF 75 25*HD 58 
 
*The distribution of the respective gene differed significantly between strains from the stated hosts (with p ≤ 0.050). Host groups are indicated as follows: 
humans (H), ruminants (R), dogs (D), rodents (X), fish (F), and other (Y). 
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